SUNPHARMA Statistics

Total Valuation

Sun Pharmaceutical Industries has a market cap or net worth of INR 4.27 trillion. The enterprise value is 4.10 trillion.

Market Cap	4.27T
Enterprise Value	4.10T

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Sun Pharmaceutical Industries has 2.40 billion shares outstanding. The number of shares has decreased by -0.14% in one year.

Current Share Class	n/a
Shares Outstanding	2.40B
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.38%
Owned by Insiders (%)	12.01%
Owned by Institutions (%)	27.07%
Float	1.04B

Valuation Ratios

The trailing PE ratio is 38.61 and the forward PE ratio is 37.55. Sun Pharmaceutical Industries's PEG ratio is 2.37.

PE Ratio	38.61
Forward PE	37.55
PS Ratio	8.48
PB Ratio	6.17
P/TBV Ratio	n/a
P/FCF Ratio	39.64
P/OCF Ratio	n/a
PEG Ratio	2.37

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.45, with an EV/FCF ratio of 38.04.

EV / Earnings	37.07
EV / Sales	8.15
EV / EBITDA	29.45
EV / EBIT	35.85
EV / FCF	38.04

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.04.

Current Ratio	2.67
Quick Ratio	1.92
Debt / Equity	0.04
Debt / EBITDA	0.18
Debt / FCF	0.24
Interest Coverage	47.90

Financial Efficiency

Return on equity (ROE) is 16.77% and return on invested capital (ROIC) is 10.44%.

Return on Equity (ROE)	16.77%
Return on Assets (ROA)	8.54%
Return on Capital (ROIC)	10.44%
Revenue Per Employee	11.70M
Profits Per Employee	2.57M
Employee Count	43,000
Asset Turnover	0.60
Inventory Turnover	1.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.83% in the last 52 weeks. The beta is 0.55, so Sun Pharmaceutical Industries's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+49.83%
50-Day Moving Average	1,859.98
200-Day Moving Average	1,653.67
Relative Strength Index (RSI)	40.91
Average Volume (20 Days)	1,974,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sun Pharmaceutical Industries had revenue of INR 503.08 billion and earned 110.54 billion in profits. Earnings per share was 46.11.

Revenue	503.08B
Gross Profit	390.41B
Operating Income	114.49B
Pretax Income	128.18B
Net Income	110.54B
EBITDA	138.02B
EBIT	114.49B
Earnings Per Share (EPS)	46.11

Full Income Statement

Balance Sheet

The company has 201.22 billion in cash and 25.72 billion in debt, giving a net cash position of 175.50 billion or 73.15 per share.

Cash & Cash Equivalents	201.22B
Total Debt	25.72B
Net Cash	175.50B
Net Cash Per Share	73.15
Equity (Book Value)	693.80B
Book Value Per Share	288.72
Working Capital	288.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 127.15 billion and capital expenditures -19.42 billion, giving a free cash flow of 107.74 billion.

Operating Cash Flow	127.15B
Capital Expenditures	-19.42B
Free Cash Flow	107.74B
FCF Per Share	44.90

Full Cash Flow Statement

Margins

Gross margin is 77.60%, with operating and profit margins of 22.76% and 21.97%.

Gross Margin	77.60%
Operating Margin	22.76%
Pretax Margin	25.48%
Profit Margin	21.97%
EBITDA Margin	27.43%
EBIT Margin	22.76%
FCF Margin	21.42%

Dividends & Yields

This stock pays an annual dividend of 13.50, which amounts to a dividend yield of 0.76%.

Dividend Per Share	13.50
Dividend Yield	0.76%
Dividend Growth (YoY)	17.39%
Years of Dividend Growth	5
Payout Ratio	28.39%
Buyback Yield	0.14%
Shareholder Yield	0.90%
Earnings Yield	2.59%
FCF Yield	2.52%

Dividend Details

Stock Splits

The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.

Last Split Date	Jul 29, 2013
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a